nodes	percent_of_prediction	percent_of_DWPC	metapath
Edetic Acid—Nephrotic syndrome—Sorafenib—liver cancer	0.0332	0.0772	CcSEcCtD
Edetic Acid—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.0273	0.0634	CcSEcCtD
Edetic Acid—Proteinuria—Sorafenib—liver cancer	0.0182	0.0424	CcSEcCtD
Edetic Acid—Protein urine present—Sorafenib—liver cancer	0.018	0.0419	CcSEcCtD
Edetic Acid—Dermatitis exfoliative—Sorafenib—liver cancer	0.0123	0.0287	CcSEcCtD
Edetic Acid—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0105	0.0244	CcSEcCtD
Edetic Acid—Lacrimation—Epirubicin—liver cancer	0.0101	0.0234	CcSEcCtD
Edetic Acid—Lacrimation—Doxorubicin—liver cancer	0.00932	0.0217	CcSEcCtD
Edetic Acid—Bone marrow depression—Epirubicin—liver cancer	0.00877	0.0204	CcSEcCtD
Edetic Acid—Bone marrow depression—Doxorubicin—liver cancer	0.00812	0.0189	CcSEcCtD
Edetic Acid—Necrosis—Epirubicin—liver cancer	0.00755	0.0176	CcSEcCtD
Edetic Acid—Glycosuria—Epirubicin—liver cancer	0.00731	0.017	CcSEcCtD
Edetic Acid—Necrosis—Doxorubicin—liver cancer	0.00698	0.0162	CcSEcCtD
Edetic Acid—Glycosuria—Doxorubicin—liver cancer	0.00676	0.0157	CcSEcCtD
Edetic Acid—Anaemia—Sorafenib—liver cancer	0.00648	0.0151	CcSEcCtD
Edetic Acid—Lacrimation increased—Epirubicin—liver cancer	0.00643	0.015	CcSEcCtD
Edetic Acid—Hyperuricaemia—Epirubicin—liver cancer	0.00638	0.0149	CcSEcCtD
Edetic Acid—Blood uric acid increased—Epirubicin—liver cancer	0.00603	0.014	CcSEcCtD
Edetic Acid—Arthralgia—Sorafenib—liver cancer	0.00596	0.0139	CcSEcCtD
Edetic Acid—Myalgia—Sorafenib—liver cancer	0.00596	0.0139	CcSEcCtD
Edetic Acid—Lacrimation increased—Doxorubicin—liver cancer	0.00595	0.0138	CcSEcCtD
Edetic Acid—Hyperuricaemia—Doxorubicin—liver cancer	0.00591	0.0137	CcSEcCtD
Edetic Acid—Blood uric acid increased—Doxorubicin—liver cancer	0.00558	0.013	CcSEcCtD
Edetic Acid—Anorexia—Sorafenib—liver cancer	0.00545	0.0127	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00521	0.0121	CcSEcCtD
Edetic Acid—Decreased appetite—Sorafenib—liver cancer	0.00497	0.0116	CcSEcCtD
Edetic Acid—Thrombophlebitis—Epirubicin—liver cancer	0.00497	0.0116	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Sorafenib—liver cancer	0.00494	0.0115	CcSEcCtD
Edetic Acid—Fatigue—Sorafenib—liver cancer	0.00493	0.0115	CcSEcCtD
Edetic Acid—Pain—Sorafenib—liver cancer	0.00489	0.0114	CcSEcCtD
Edetic Acid—Thrombophlebitis—Doxorubicin—liver cancer	0.0046	0.0107	CcSEcCtD
Edetic Acid—Dermatitis exfoliative—Epirubicin—liver cancer	0.00456	0.0106	CcSEcCtD
Edetic Acid—Body temperature increased—Sorafenib—liver cancer	0.00452	0.0105	CcSEcCtD
Edetic Acid—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00422	0.00981	CcSEcCtD
Edetic Acid—Asthenia—Sorafenib—liver cancer	0.0041	0.00955	CcSEcCtD
Edetic Acid—Diarrhoea—Sorafenib—liver cancer	0.00391	0.0091	CcSEcCtD
Edetic Acid—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00387	0.00901	CcSEcCtD
Edetic Acid—Vomiting—Sorafenib—liver cancer	0.00364	0.00846	CcSEcCtD
Edetic Acid—Rash—Sorafenib—liver cancer	0.00361	0.00839	CcSEcCtD
Edetic Acid—Dermatitis—Sorafenib—liver cancer	0.0036	0.00838	CcSEcCtD
Edetic Acid—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00358	0.00834	CcSEcCtD
Edetic Acid—Headache—Sorafenib—liver cancer	0.00358	0.00834	CcSEcCtD
Edetic Acid—Pancytopenia—Epirubicin—liver cancer	0.00353	0.00821	CcSEcCtD
Edetic Acid—Nausea—Sorafenib—liver cancer	0.0034	0.0079	CcSEcCtD
Edetic Acid—CYP19A1—Metapathway biotransformation—GSTA4—liver cancer	0.00332	0.00582	CbGpPWpGaD
Edetic Acid—ADA—C-MYB transcription factor network—CCND1—liver cancer	0.00331	0.00581	CbGpPWpGaD
Edetic Acid—CYP1A2—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00329	0.00576	CbGpPWpGaD
Edetic Acid—CYP19A1—Biological oxidations—GSTA2—liver cancer	0.00328	0.00575	CbGpPWpGaD
Edetic Acid—Pancytopenia—Doxorubicin—liver cancer	0.00327	0.0076	CcSEcCtD
Edetic Acid—ADA—C-MYB transcription factor network—CDKN1A—liver cancer	0.0032	0.00562	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—AHR—liver cancer	0.00318	0.00557	CbGpPWpGaD
Edetic Acid—CYP19A1—Ovarian Infertility Genes—CDKN1B—liver cancer	0.00317	0.00555	CbGpPWpGaD
Edetic Acid—CYP19A1—Biological oxidations—GSTA1—liver cancer	0.00316	0.00555	CbGpPWpGaD
Edetic Acid—Haematuria—Epirubicin—liver cancer	0.00316	0.00735	CcSEcCtD
Edetic Acid—CYP19A1—Biological oxidations—NAT2—liver cancer	0.00313	0.00549	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.00311	0.00545	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—liver cancer	0.00311	0.00545	CbGpPWpGaD
Edetic Acid—CYP1A2—Xenobiotics—CYP1A1—liver cancer	0.0031	0.00543	CbGpPWpGaD
Edetic Acid—CYP19A1—Metapathway biotransformation—NAT2—liver cancer	0.00309	0.00541	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—liver cancer	0.00303	0.00531	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.00303	0.00531	CbGpPWpGaD
Edetic Acid—CYP1A2—Tamoxifen metabolism—CYP1A1—liver cancer	0.00298	0.00522	CbGpPWpGaD
Edetic Acid—Hypoaesthesia—Epirubicin—liver cancer	0.00296	0.00689	CcSEcCtD
Edetic Acid—Haematuria—Doxorubicin—liver cancer	0.00292	0.0068	CcSEcCtD
Edetic Acid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00282	0.00494	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—PPARA—liver cancer	0.00281	0.00492	CbGpPWpGaD
Edetic Acid—ADA—p73 transcription factor network—MYC—liver cancer	0.00279	0.00489	CbGpPWpGaD
Edetic Acid—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00276	0.00484	CbGpPWpGaD
Edetic Acid—Hypoaesthesia—Doxorubicin—liver cancer	0.00274	0.00637	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00272	0.00476	CbGpPWpGaD
Edetic Acid—Chills—Epirubicin—liver cancer	0.00267	0.00621	CcSEcCtD
Edetic Acid—CYP1A2—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00266	0.00467	CbGpPWpGaD
Edetic Acid—ADA—C-MYB transcription factor network—MYC—liver cancer	0.00266	0.00466	CbGpPWpGaD
Edetic Acid—CYP19A1—Metapathway biotransformation—GPX3—liver cancer	0.00262	0.0046	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—UGDH—liver cancer	0.0026	0.00456	CbGpPWpGaD
Edetic Acid—CYP1A2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00254	0.00446	CbGpPWpGaD
Edetic Acid—CYP19A1—Biological oxidations—HPGDS—liver cancer	0.0025	0.00439	CbGpPWpGaD
Edetic Acid—Chills—Doxorubicin—liver cancer	0.00247	0.00575	CcSEcCtD
Edetic Acid—ADA—C-MYB transcription factor network—KRAS—liver cancer	0.00245	0.0043	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—EPT1—liver cancer	0.00244	0.00428	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—UGDH—liver cancer	0.00242	0.00425	CbGpPWpGaD
Edetic Acid—Ill-defined disorder—Epirubicin—liver cancer	0.0024	0.00559	CcSEcCtD
Edetic Acid—Anaemia—Epirubicin—liver cancer	0.00239	0.00557	CcSEcCtD
Edetic Acid—CYP1A2—Phase II conjugation—GSTA3—liver cancer	0.00238	0.00417	CbGpPWpGaD
Edetic Acid—CYP1A2—Estrogen Receptor Pathway—JUN—liver cancer	0.00234	0.00411	CbGpPWpGaD
Edetic Acid—Malaise—Epirubicin—liver cancer	0.00233	0.00543	CcSEcCtD
Edetic Acid—ADA—Circadian rythm related genes—PPARG—liver cancer	0.00232	0.00407	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—TAT—liver cancer	0.00232	0.00406	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00231	0.00406	CbGpPWpGaD
Edetic Acid—CYP1A2—Melatonin metabolism and effects—CYP1A1—liver cancer	0.0023	0.00403	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—liver cancer	0.0023	0.00402	CbGpPWpGaD
Edetic Acid—Ill-defined disorder—Doxorubicin—liver cancer	0.00222	0.00517	CcSEcCtD
Edetic Acid—Anaemia—Doxorubicin—liver cancer	0.00221	0.00515	CcSEcCtD
Edetic Acid—CYP1A2—Tryptophan metabolism—CYP2E1—liver cancer	0.00221	0.00388	CbGpPWpGaD
Edetic Acid—Myalgia—Epirubicin—liver cancer	0.0022	0.00513	CcSEcCtD
Edetic Acid—Arthralgia—Epirubicin—liver cancer	0.0022	0.00513	CcSEcCtD
Edetic Acid—Discomfort—Epirubicin—liver cancer	0.00218	0.00507	CcSEcCtD
Edetic Acid—CYP1A2—Phase II conjugation—GSTA4—liver cancer	0.00218	0.00381	CbGpPWpGaD
Edetic Acid—Malaise—Doxorubicin—liver cancer	0.00216	0.00503	CcSEcCtD
Edetic Acid—CYP1A2—Phase II conjugation—GSTA2—liver cancer	0.00212	0.00372	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—SERPINE1—liver cancer	0.00209	0.00366	CbGpPWpGaD
Edetic Acid—ADA—C-MYB transcription factor network—HRAS—liver cancer	0.00209	0.00366	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—GSTA1—liver cancer	0.00205	0.00359	CbGpPWpGaD
Edetic Acid—Myalgia—Doxorubicin—liver cancer	0.00204	0.00475	CcSEcCtD
Edetic Acid—Arthralgia—Doxorubicin—liver cancer	0.00204	0.00475	CcSEcCtD
Edetic Acid—CYP19A1—Biological oxidations—CYP2E1—liver cancer	0.00204	0.00357	CbGpPWpGaD
Edetic Acid—CYP1A2—Estrogen Receptor Pathway—STAT3—liver cancer	0.00203	0.00356	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—NAT2—liver cancer	0.00202	0.00355	CbGpPWpGaD
Edetic Acid—Discomfort—Doxorubicin—liver cancer	0.00202	0.00469	CcSEcCtD
Edetic Acid—Anorexia—Epirubicin—liver cancer	0.00201	0.00469	CcSEcCtD
Edetic Acid—CYP19A1—Metapathway biotransformation—CYP2E1—liver cancer	0.00201	0.00353	CbGpPWpGaD
Edetic Acid—Hypotension—Epirubicin—liver cancer	0.00197	0.0046	CcSEcCtD
Edetic Acid—CYP19A1—FSH signaling pathway—AKT1—liver cancer	0.00193	0.00338	CbGpPWpGaD
Edetic Acid—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00193	0.00448	CcSEcCtD
Edetic Acid—CYP1A2—Arachidonic acid metabolism—GGT1—liver cancer	0.0019	0.00333	CbGpPWpGaD
Edetic Acid—Paraesthesia—Epirubicin—liver cancer	0.0019	0.00442	CcSEcCtD
Edetic Acid—CYP19A1—Biological oxidations—GGT1—liver cancer	0.00187	0.00328	CbGpPWpGaD
Edetic Acid—Anorexia—Doxorubicin—liver cancer	0.00186	0.00434	CcSEcCtD
Edetic Acid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00185	0.00325	CbGpPWpGaD
Edetic Acid—Decreased appetite—Epirubicin—liver cancer	0.00184	0.00427	CcSEcCtD
Edetic Acid—Hypotension—Doxorubicin—liver cancer	0.00183	0.00425	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Epirubicin—liver cancer	0.00182	0.00425	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.00182	0.0032	CbGpPWpGaD
Edetic Acid—Fatigue—Epirubicin—liver cancer	0.00182	0.00424	CcSEcCtD
Edetic Acid—Pain—Epirubicin—liver cancer	0.00181	0.00421	CcSEcCtD
Edetic Acid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00179	0.00314	CbGpPWpGaD
Edetic Acid—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00178	0.00415	CcSEcCtD
Edetic Acid—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00177	0.0031	CbGpPWpGaD
Edetic Acid—Paraesthesia—Doxorubicin—liver cancer	0.00176	0.00409	CcSEcCtD
Edetic Acid—Feeling abnormal—Epirubicin—liver cancer	0.00174	0.00405	CcSEcCtD
Edetic Acid—Decreased appetite—Doxorubicin—liver cancer	0.0017	0.00396	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00169	0.00393	CcSEcCtD
Edetic Acid—Fatigue—Doxorubicin—liver cancer	0.00169	0.00392	CcSEcCtD
Edetic Acid—CYP19A1—Biological oxidations—GSTP1—liver cancer	0.00168	0.00295	CbGpPWpGaD
Edetic Acid—Pain—Doxorubicin—liver cancer	0.00167	0.00389	CcSEcCtD
Edetic Acid—Body temperature increased—Epirubicin—liver cancer	0.00167	0.00389	CcSEcCtD
Edetic Acid—CYP19A1—Metapathway biotransformation—GSTP1—liver cancer	0.00166	0.00291	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—JUN—liver cancer	0.00164	0.00288	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—HPGDS—liver cancer	0.00162	0.00283	CbGpPWpGaD
Edetic Acid—Feeling abnormal—Doxorubicin—liver cancer	0.00161	0.00375	CcSEcCtD
Edetic Acid—CYP1A2—Tryptophan metabolism—CYP1A1—liver cancer	0.00159	0.00279	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.00159	0.00279	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.00159	0.00279	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CPT1B—liver cancer	0.00157	0.00276	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GLUL—liver cancer	0.00157	0.00276	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—MAPK8—liver cancer	0.00156	0.00273	CbGpPWpGaD
Edetic Acid—Body temperature increased—Doxorubicin—liver cancer	0.00155	0.0036	CcSEcCtD
Edetic Acid—CYP19A1—Biological oxidations—GSTM1—liver cancer	0.00155	0.00271	CbGpPWpGaD
Edetic Acid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00153	0.00269	CbGpPWpGaD
Edetic Acid—CYP19A1—Metapathway biotransformation—GSTM1—liver cancer	0.00152	0.00267	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—NR1H4—liver cancer	0.00152	0.00266	CbGpPWpGaD
Edetic Acid—Asthenia—Epirubicin—liver cancer	0.00152	0.00353	CcSEcCtD
Edetic Acid—ADA—Metabolism—GSTA3—liver cancer	0.00149	0.00262	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00149	0.00261	CbGpPWpGaD
Edetic Acid—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00149	0.00261	CbGpPWpGaD
Edetic Acid—CYP19A1—Biological oxidations—CYP1A1—liver cancer	0.00146	0.00257	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00145	0.00254	CbGpPWpGaD
Edetic Acid—Diarrhoea—Epirubicin—liver cancer	0.00145	0.00336	CcSEcCtD
Edetic Acid—CYP19A1—Metapathway biotransformation—CYP1A1—liver cancer	0.00144	0.00253	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00144	0.00252	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.00142	0.00248	CbGpPWpGaD
Edetic Acid—Asthenia—Doxorubicin—liver cancer	0.0014	0.00326	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.00139	0.00244	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.00137	0.00241	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GSTA4—liver cancer	0.00137	0.00239	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.00135	0.00236	CbGpPWpGaD
Edetic Acid—Vomiting—Epirubicin—liver cancer	0.00134	0.00313	CcSEcCtD
Edetic Acid—Diarrhoea—Doxorubicin—liver cancer	0.00134	0.00311	CcSEcCtD
Edetic Acid—Rash—Epirubicin—liver cancer	0.00133	0.0031	CcSEcCtD
Edetic Acid—Dermatitis—Epirubicin—liver cancer	0.00133	0.0031	CcSEcCtD
Edetic Acid—ADA—Metabolism—GSTA2—liver cancer	0.00133	0.00233	CbGpPWpGaD
Edetic Acid—Headache—Epirubicin—liver cancer	0.00132	0.00308	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.00132	0.00231	CbGpPWpGaD
Edetic Acid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00129	0.00226	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GSTA1—liver cancer	0.00128	0.00225	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.00127	0.00223	CbGpPWpGaD
Edetic Acid—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00127	0.00223	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—NAT2—liver cancer	0.00127	0.00223	CbGpPWpGaD
Edetic Acid—Nausea—Epirubicin—liver cancer	0.00126	0.00292	CcSEcCtD
Edetic Acid—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.00125	0.0022	CbGpPWpGaD
Edetic Acid—Vomiting—Doxorubicin—liver cancer	0.00124	0.00289	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.00124	0.00217	CbGpPWpGaD
Edetic Acid—Rash—Doxorubicin—liver cancer	0.00123	0.00287	CcSEcCtD
Edetic Acid—Dermatitis—Doxorubicin—liver cancer	0.00123	0.00287	CcSEcCtD
Edetic Acid—Headache—Doxorubicin—liver cancer	0.00122	0.00285	CcSEcCtD
Edetic Acid—ADA—Metabolism—ALDOB—liver cancer	0.00122	0.00213	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.00121	0.00212	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.0012	0.0021	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.0012	0.0021	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—NAT2—liver cancer	0.00118	0.00207	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.00117	0.00205	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.00117	0.00205	CbGpPWpGaD
Edetic Acid—Nausea—Doxorubicin—liver cancer	0.00116	0.0027	CcSEcCtD
Edetic Acid—ADA—Metabolism—CRABP1—liver cancer	0.00116	0.00204	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.0011	0.00193	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—UGDH—liver cancer	0.0011	0.00192	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.00109	0.00191	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—TP53—liver cancer	0.00109	0.0019	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00104	0.00183	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—EPT1—liver cancer	0.00103	0.00181	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—HPGDS—liver cancer	0.00101	0.00178	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000999	0.00175	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—IL6—liver cancer	0.000994	0.00174	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000992	0.00174	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000978	0.00171	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—TAT—liver cancer	0.000976	0.00171	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000976	0.00171	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00096	0.00168	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000946	0.00166	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PSMD10—liver cancer	0.000904	0.00159	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PSMA4—liver cancer	0.000904	0.00159	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000897	0.00157	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000896	0.00157	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000896	0.00157	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GOT2—liver cancer	0.00088	0.00154	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000877	0.00154	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000875	0.00153	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.000873	0.00153	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000872	0.00153	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.000865	0.00152	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000853	0.0015	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CYP2E1—liver cancer	0.000827	0.00145	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000827	0.00145	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CYCS—liver cancer	0.000774	0.00136	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000771	0.00135	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000761	0.00134	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.00076	0.00133	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GGT1—liver cancer	0.000759	0.00133	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GOT1—liver cancer	0.000759	0.00133	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000745	0.00131	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000719	0.00126	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000708	0.00124	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000701	0.00123	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000686	0.0012	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000684	0.0012	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GSTP1—liver cancer	0.000682	0.0012	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—HMOX1—liver cancer	0.000673	0.00118	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CPT1B—liver cancer	0.000664	0.00116	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GLUL—liver cancer	0.000664	0.00116	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000647	0.00114	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NR1H4—liver cancer	0.00064	0.00112	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000639	0.00112	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000639	0.00112	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000636	0.00111	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000634	0.00111	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTA3—liver cancer	0.000629	0.0011	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000627	0.0011	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GSTM1—liver cancer	0.000627	0.0011	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CYP1A1—liver cancer	0.000594	0.00104	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000584	0.00102	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000576	0.00101	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTA4—liver cancer	0.000575	0.00101	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000575	0.00101	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000564	0.000988	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000562	0.000986	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTA2—liver cancer	0.000561	0.000983	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—MTHFR—liver cancer	0.000554	0.000971	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000554	0.000971	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.000546	0.000958	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PPARA—liver cancer	0.000543	0.000953	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000543	0.000953	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTA1—liver cancer	0.000541	0.000949	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000538	0.000944	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NAT2—liver cancer	0.000535	0.000938	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000514	0.000902	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ALDOB—liver cancer	0.000513	0.000899	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CRABP1—liver cancer	0.000489	0.000858	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000486	0.000852	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CG—liver cancer	0.000465	0.000816	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PPARG—liver cancer	0.000449	0.000788	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000441	0.000773	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—HPGDS—liver cancer	0.000428	0.00075	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000425	0.000746	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000415	0.000728	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—UGDH—liver cancer	0.000414	0.000726	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CD—liver cancer	0.000409	0.000717	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—ALB—liver cancer	0.000404	0.000708	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—EPT1—liver cancer	0.000389	0.000683	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000387	0.000679	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000382	0.00067	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PSMD10—liver cancer	0.000381	0.000668	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PSMA4—liver cancer	0.000381	0.000668	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GOT2—liver cancer	0.000371	0.00065	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—TAT—liver cancer	0.000369	0.000647	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000363	0.000637	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CB—liver cancer	0.000357	0.000625	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CYP2E1—liver cancer	0.000349	0.000611	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000338	0.000592	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CYCS—liver cancer	0.000326	0.000572	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GOT1—liver cancer	0.00032	0.000561	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GGT1—liver cancer	0.00032	0.000561	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTP1—liver cancer	0.000288	0.000504	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—HMOX1—liver cancer	0.000284	0.000497	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000272	0.000477	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTM1—liver cancer	0.000264	0.000463	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CPT1B—liver cancer	0.000251	0.00044	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GLUL—liver cancer	0.000251	0.00044	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CYP1A1—liver cancer	0.00025	0.000439	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NR1H4—liver cancer	0.000242	0.000424	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTA3—liver cancer	0.000238	0.000417	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—MTHFR—liver cancer	0.000234	0.000409	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PPARA—liver cancer	0.000229	0.000402	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTA4—liver cancer	0.000218	0.000382	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CA—liver cancer	0.000217	0.000381	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000213	0.000373	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTA2—liver cancer	0.000212	0.000372	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000206	0.000361	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTA1—liver cancer	0.000205	0.000359	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NAT2—liver cancer	0.000202	0.000355	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CG—liver cancer	0.000196	0.000344	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000195	0.000341	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ALDOB—liver cancer	0.000194	0.00034	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PPARG—liver cancer	0.000189	0.000332	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CRABP1—liver cancer	0.000185	0.000324	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—AKT1—liver cancer	0.000178	0.000311	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CD—liver cancer	0.000172	0.000302	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ALB—liver cancer	0.00017	0.000299	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000167	0.000292	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—HPGDS—liver cancer	0.000162	0.000284	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000161	0.000282	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CB—liver cancer	0.00015	0.000264	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000146	0.000257	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000145	0.000253	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PSMA4—liver cancer	0.000144	0.000253	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PSMD10—liver cancer	0.000144	0.000253	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GOT2—liver cancer	0.00014	0.000246	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CYP2E1—liver cancer	0.000132	0.000231	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000128	0.000224	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CYCS—liver cancer	0.000123	0.000216	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GGT1—liver cancer	0.000121	0.000212	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GOT1—liver cancer	0.000121	0.000212	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTP1—liver cancer	0.000109	0.000191	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—HMOX1—liver cancer	0.000107	0.000188	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTM1—liver cancer	9.99e-05	0.000175	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CYP1A1—liver cancer	9.47e-05	0.000166	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CA—liver cancer	9.16e-05	0.000161	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—MTHFR—liver cancer	8.83e-05	0.000155	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PPARA—liver cancer	8.66e-05	0.000152	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.78e-05	0.000136	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—AKT1—liver cancer	7.49e-05	0.000131	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CG—liver cancer	7.42e-05	0.00013	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PPARG—liver cancer	7.16e-05	0.000126	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CD—liver cancer	6.52e-05	0.000114	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ALB—liver cancer	6.44e-05	0.000113	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CB—liver cancer	5.68e-05	9.97e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CA—liver cancer	3.47e-05	6.08e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—AKT1—liver cancer	2.83e-05	4.96e-05	CbGpPWpGaD
